ProMIS Neurosciences, Inc.
PMN
$10.57
$0.080.76%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.67M | -11.58M | -10.12M | -7.35M | -238.20K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 197.60K | 197.10K | 212.00K | 245.30K | -4.91M |
| Change in Net Operating Assets | 1.19M | 1.33M | 6.05M | 2.18M | -3.56M |
| Cash from Operations | -9.28M | -10.06M | -3.85M | -4.93M | -8.72M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -700.00 | -- | -- | -- | -700.00 |
| Cash from Investing | -700.00 | -- | -- | -- | -700.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 20.25M | -- | -- | 470.00K |
| Repurchase of Common Stock | -10.17M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 10.17M | 697.70K | -- | -- | -- |
| Cash from Financing | 0.00 | 20.94M | -- | -- | 470.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -9.28M | 10.89M | -3.85M | -4.93M | -8.25M |